However, Th22 cells also showed enhanced capacity to produce IL-22 and IL-13 in EOCRC, which could promote aggressive tumor behavior and shape an immunosuppressive environment favorable to tumor survival and growth (72). This evidence concerns the gene IL22 and neoplasm.